Year archive

Giant Biogene Holding Co., Ltd — 2022 filings

All 17 regulatory filings released by Giant Biogene Holding Co., Ltd (2367) in 2022, sourced directly from the official regulator.

17 Filings

2022 Period

2022 filings (17)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2022 Regulatory Filings	2022-12-05	English
Next Day Disclosure Return Share Issue/Capital Change	2022-11-30	English
FULL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD Capital/Financing Update	2022-11-27	English
List of Directors And Their Roles And Functions Board/Management Information	2022-11-03	English
Remuneration Committee - Terms of Reference Remuneration Information	2022-11-03	English
Nomination Committee - Terms of Reference Governance Information	2022-11-02	English
Audit Committee - Terms of Reference Governance Information	2022-11-02	English
Third Amended And Restated Memorandum And Articles of Association Governance Information	2022-11-02	English
Announcement of Final Offer Price And Allotment Results Share Issue/Capital Change	2022-11-02	English
Documents on Display Regulatory Filings	2022-10-25	English
GREEN APPLICATION FORM Capital/Financing Update	2022-10-25	English
GLOBAL OFFERING Regulatory Filings	2022-10-25	English
GLOBAL OFFERING Capital/Financing Update	2022-10-25	English
PHIP (1st submission) Regulatory Filings	2022-10-09	English
PHIP (1st submission) Regulatory Filings	2022-10-09	English
Application Proof (1st submission) Regulatory Filings	2022-05-05	English
Application Proof (1st submission) Regulatory Filings	2022-05-05	English